Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein. (Q47830000)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 1998

Language	Label	Description	Also known as
English	Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein.	scientific article published in April 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9569470

Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein. (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9569470

Plasmodium falciparum

1 reference

based on heuristic

inferred from title

Ruth Nussenzweig

5

object named as

R Nussenzweig

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

author name string

E H Nardin

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9569470

J M Calvo-Calle

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9569470

G A Oliveira

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9569470

P Clavijo

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9569470

R Simon

6

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9569470

W Zeng

7

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9569470

K Rose

8

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9569470

language of work or name

0 references

publication date

1 April 1998

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9569470

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9569470

16

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9569470

6

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9569470

590-600

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9569470

The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale for the development of an engineered sporozoite malaria vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective anti-sporozoite antibodies induced by a chemically defined synthetic vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of theP. falciparum circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity of an alum-adsorbed synthetic multiple-antigen peptide based on B- and T-cell epitopes of the Plasmodium falciparum CS protein: possible vaccine application

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A synthetic peptide-based polyoxime vaccine construct of high purity and activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural peptides as building blocks for the synthesis of large protein-like molecules with hydrazone and oxime linkages

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale for development of a synthetic vaccine against plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H-2 haplotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900238-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(97)00238-7

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9569470

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9569470

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47830000&oldid=1775328942"